BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25792467)

  • 21. Change in Spontaneous Swallowing Frequency in HNC Patients Undergoing C/RT.
    Carnaby GD; Madhavan A; Barikroo A; Crary M
    Otolaryngol Head Neck Surg; 2022 Apr; 166(4):727-733. PubMed ID: 34154425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrical stimulation of post-irradiated head and neck squamous cell carcinoma to improve xerostomia.
    Pattani KM; McDuffie CM; Morgan M; Armstrong C; Nathan CO
    J La State Med Soc; 2010; 162(1):21-5. PubMed ID: 20336953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of minor salivary glands in developing patient-rated xerostomia and sticky saliva during day and night.
    Beetz I; Schilstra C; Visink A; van der Schaaf A; Bijl HP; van der Laan BF; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2013 Nov; 109(2):311-6. PubMed ID: 23953752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial.
    Lu W; Wayne PM; Davis RB; Buring JE; Li H; Macklin EA; Lorch JH; Burke E; Haddad TC; Goguen LA; Rosenthal DS; Tishler RB; Posner MR; Haddad RI
    Oncologist; 2016 Dec; 21(12):1522-1529. PubMed ID: 27511906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of swallowing and speech problems in daily life after chemoradiation for head and neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI.
    Rinkel RN; Verdonck-de Leeuw IM; Doornaert P; Buter J; de Bree R; Langendijk JA; Aaronson NK; Leemans CR
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1849-55. PubMed ID: 26071622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is EAT-10 Useful to Assess Swallowing during the Chemo-Radiotherapy Phase in Patients with Head and Neck Cancer? A Pilot Study.
    Bofill-Soler N; Guillen-Sola A; Marco E; Nieto-Cadalso S; Barrera MC; Pera-Cegarra O; Membrive I; Duran X; Foro P
    Ann Otol Rhinol Laryngol; 2021 Jul; 130(7):689-698. PubMed ID: 33094639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic dilatation improves long-term dysphagia following head and neck cancer therapies: a randomized control trial.
    Wu PI; Szczesniak MM; Maclean J; Graham PH; Quon H; Choo L; Cook IJ
    Dis Esophagus; 2019 Jun; 32(6):. PubMed ID: 30462194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A swallow preservation protocol improves function for veterans receiving chemoradiation for head and neck cancer.
    Peng KA; Kuan EC; Unger L; Lorentz WC; Wang MB; Long JL
    Otolaryngol Head Neck Surg; 2015 May; 152(5):863-7. PubMed ID: 25829388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia.
    Yahya N; Linge A; Leger K; Maile T; Kemper M; Haim D; Jöhrens K; Troost EGC; Krause M; Löck S
    Acta Oncol; 2022 Jul; 61(7):856-863. PubMed ID: 35657056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Change in Tongue Pressure and Salivary Flow Rate on Swallow Efficiency Following Chemoradiation Treatment for Head and Neck Cancer.
    Rogus-Pulia NM; Larson C; Mittal BB; Pierce M; Zecker S; Kennelty K; Kind A; Connor NP
    Dysphagia; 2016 Oct; 31(5):687-96. PubMed ID: 27492408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives.
    Wilson JA; Carding PN; Patterson JM
    Otolaryngol Head Neck Surg; 2011 Nov; 145(5):767-71. PubMed ID: 21746839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer.
    Anand AK; Chaudhoory AR; Shukla A; Negi PS; Sinha SN; Babu AA; Munjal RK; Dewan AK; Kumar K; Doval DC; Vaid AK
    Br J Radiol; 2008 Nov; 81(971):865-71. PubMed ID: 18941046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling Dose Response for Late Dysphagia in Patients With Head and Neck Cancer in the Modern Era of Definitive Chemoradiation.
    Tsai CJ; Jackson A; Setton J; Riaz N; McBride S; Leeman J; Kowalski A; Happersett L; Lee NY
    JCO Clin Cancer Inform; 2017 Nov; 1():1-7. PubMed ID: 30657398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy.
    Ramaekers BL; Joore MA; Grutters JP; van den Ende P; Jong Jd; Houben R; Lambin P; Christianen M; Beetz I; Pijls-Johannesma M; Langendijk JA
    Oral Oncol; 2011 Aug; 47(8):768-74. PubMed ID: 21683647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
    Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for late dysphagia after (chemo)radiotherapy for head and neck cancer: A systematic methodological review.
    Jiang N; Zhang LJ; Li LY; Zhao Y; Eisele DW
    Head Neck; 2016 May; 38(5):792-800. PubMed ID: 25532723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic.
    Rütten H; Pop LA; Janssens GO; Takes RP; Knuijt S; Rooijakkers AF; van den Berg M; Merkx MA; van Herpen CM; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):923-9. PubMed ID: 21095074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
    Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-volume response in acute dysphagia toxicity: Validating QUANTEC recommendations into clinical practice for head and neck radiotherapy.
    Anderson NJ; Wada M; Schneider-Kolsky M; Rolfo M; Joon DL; Khoo V
    Acta Oncol; 2014 Oct; 53(10):1305-11. PubMed ID: 24980044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.